Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$42.05 - $47.77 $1.07 Million - $1.22 Million
25,439 Added 210.31%
37,535 $1.63 Million
Q1 2022

May 09, 2022

SELL
$40.23 - $47.74 $72,414 - $85,932
-1,800 Reduced 12.95%
12,096 $527,000
Q4 2021

Feb 07, 2022

SELL
$38.88 - $45.31 $159,096 - $185,408
-4,092 Reduced 22.75%
13,896 $613,000
Q3 2021

Nov 04, 2021

SELL
$38.79 - $43.16 $20,907 - $23,263
-539 Reduced 2.91%
17,988 $687,000
Q2 2021

Aug 05, 2021

SELL
$36.52 - $41.46 $182 - $207
-5 Reduced 0.03%
18,527 $738,000
Q1 2021

May 05, 2021

SELL
$34.27 - $40.01 $303,460 - $354,288
-8,855 Reduced 32.33%
18,532 $661,000
Q4 2020

Feb 08, 2021

SELL
$34.07 - $39.94 $211,881 - $248,386
-6,219 Reduced 18.51%
27,387 $1.01 Million
Q3 2020

Nov 05, 2020

BUY
$38.11 - $42.99 $331,061 - $373,454
8,687 Added 34.86%
33,606 $1.27 Million
Q2 2020

Aug 05, 2020

BUY
$37.87 - $43.58 $69,605 - $80,100
1,838 Added 7.96%
24,919 $1.02 Million
Q1 2020

May 01, 2020

SELL
$32.47 - $48.83 $184,624 - $277,647
-5,686 Reduced 19.77%
23,081 $875,000
Q4 2019

Feb 06, 2020

SELL
$42.0 - $48.25 $64,848 - $74,498
-1,544 Reduced 5.09%
28,767 $1.35 Million
Q3 2019

Nov 01, 2019

BUY
$40.46 - $43.52 $18,004 - $19,366
445 Added 1.49%
30,311 $1.29 Million
Q2 2019

Aug 01, 2019

BUY
$39.4 - $42.7 $21,630 - $23,442
549 Added 1.87%
29,866 $1.2 Million
Q1 2019

Apr 30, 2019

BUY
$38.57 - $42.69 $118,448 - $131,100
3,071 Added 11.7%
29,317 $1.23 Million
Q4 2018

Feb 06, 2019

BUY
$37.8 - $42.69 $146,097 - $164,996
3,865 Added 17.27%
26,246 $1 Million
Q3 2018

Oct 29, 2018

BUY
$39.75 - $42.69 $90,789 - $97,503
2,284 Added 11.36%
22,381 $899,000
Q2 2018

Jul 27, 2018

BUY
$39.61 - $42.76 $18,339 - $19,797
463 Added 2.36%
20,097 $810,000
Q1 2018

May 11, 2018

BUY
$36.18 - $40.15 $418,892 - $464,856
11,578 Added 143.72%
19,634 $767,000
Q4 2017

Jan 31, 2018

BUY
$35.34 - $41.9 $284,699 - $337,546
8,056
8,056 $286,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.